Marcus Keatinge

pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics

Engineering precision nanoparticles for drug delivery

Parkinson's disease

CD22 blockade restores homeostatic microglial phagocytosis in ageing brains

Hallmarks of aging: An expanding universe

Overview of General and Discriminating Markers of Differential Microglia Phenotypes

Macrophages in immunoregulation and therapeutics

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

NAD+ homeostasis in health and disease

Oxidative Stress in Cancer

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

GBA1-associated parkinsonism: new insights and therapeutic opportunities

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

Microglial Corpse Clearance: Lessons From Macrophages

Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway

ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease

The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease

Dynamic control of proinflammatory cytokines Il-1β and Tnf-α by macrophages in zebrafish spinal cord regeneration

Brain tumours repurpose endogenous neuron to microglia signalling mechanisms to promote their own proliferation

Rapid clearance of cellular debris by microglia limits secondary neuronal cell death after brain injury in vivo

TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency